Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

View source ↗

Summary

This ClinicalTrials.gov study is recruiting to evaluate autophagy and GALIG gene products in HIV-1 infected patients, including those on antiretroviral therapy,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: Autophagy, Galectins | Status: RECRUITING